# A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants

> **NCT07290283** · PHASE1 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 176 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** AZD3974
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07290283
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-10
- **Primary completion:** 2026-10-21
- **Final completion:** 2026-10-21
- **Target enrollment:** 176 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07290283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07290283, "A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07290283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*